Neuropsychological Profiles and Musical Engagement in Parkinson's and Alzheimer's Disease

NCT ID: NCT06688968

Last Updated: 2025-03-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-02-04

Study Completion Date

2025-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this Multicenter observational pilot study is to Compare the specifics of musical engagement (behaviors related to music in everyday life) in subjects aged over 60 with Alzheimer s disease, Parkinson s disease and control subjects.

The main questions it aims to answer are:

1. The description of different profiles of musical engagement in early-stage AD, in PD and in healthy elderly subjects.
2. The extent of executive, mnestic and hedonic dysfunctions will impact differently on emotional engagement, autobiographical evocation and sensitivity to musical reward, and will therefore enable distinct profiles to be drawn up.

Participants will have an intervention consisting of an interview with a neuropsychologist lasting approximately 2 hours, including :

* A semi-structured interview to check the participants eligibility and gather demographic data.
* Neuropsychological tests and questionnaires will then be administered.
* A relative of the study participant will help complete questionnaires.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Music therapy appears to be highly relevant as a Non-Medication Intervention in Alzheimer s (AD) and Parkinson s disease (PD). It is said to reduce depressive symptoms following music therapy sessions in dementia . With regard to Parkinson s disease, music therapy brings benefits in terms of motor skills, communication, breathing and emotional aspects. Reviews point to the need to differentiate beneficial effects according to different pathologies.

To date, no study has investigated the evolution of sensitivity to musical reward in AD. Furthermore, no study has discriminated the evolution of musical engagement in several neurodegenerative pathologies.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alzheimer Disease, Early Onset Parkinsons Disease with Dementia Non Pharmacological Intervention

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Multicenter observational pilot study
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

patient with early-onset Alzheimer's disease (AD)

patients followed up at the Centre Mémoire de Ressources et de Recherche (CMRR) of Montpellier, over 60 with Alzheimer's disease who have cognitive impairment based on an MMSE (Mini Mental State Examination) ≥ 20 and live at home with a relative

Group Type EXPERIMENTAL

neuropsychologist interview

Intervention Type BEHAVIORAL

It will take place either at the hospital or at the participant's home.

This interview will consist of :

* socio-demographic data collection
* neuropsychological tests:

* MMSE test (Mini Mental State Examination) cognitive function
* RL-RI-16 test (16-item free recall/indexed recall test)
* BECS test (Semantic knowledge assessment battery )
* WCST test (Wisconsin Card Sorting Test )
* Musical Cognition Test
* Help from the participant's relative to answer certain questions, in particular the MuseEQ-24 questionnaire

questionnaire

Intervention Type BEHAVIORAL

The participant answers questionnaires:

* Questionnaire MusEQ-24 self reported (Music Engagement Questionnaire)
* Questionnaire BMRQ (Barcelona Reward Music Questionnaire)
* Questionnaire SHAPS (Snaith-Hamilton Pleasure Scale)
* Questionnaire LARS (Lille's Apathy Rating Scale)
* Questionnaire PHQ-9 (Patient Health Questionnaire 9 items)

patients with parkinson's disease (PD)

patients followed up at the Center Expert Parkinson of Montpellier (CEPMo), over 60 with Parkinson's disease who have cognitive impairment based on an MMSE (Mini Mental State Examination) ≥ 20 and live at home with a relative

Group Type ACTIVE_COMPARATOR

neuropsychologist interview

Intervention Type BEHAVIORAL

It will take place either at the hospital or at the participant's home.

This interview will consist of :

* socio-demographic data collection
* neuropsychological tests:

* MMSE test (Mini Mental State Examination) cognitive function
* RL-RI-16 test (16-item free recall/indexed recall test)
* BECS test (Semantic knowledge assessment battery )
* WCST test (Wisconsin Card Sorting Test )
* Musical Cognition Test
* Help from the participant's relative to answer certain questions, in particular the MuseEQ-24 questionnaire

questionnaire

Intervention Type BEHAVIORAL

The participant answers questionnaires:

* Questionnaire MusEQ-24 self reported (Music Engagement Questionnaire)
* Questionnaire BMRQ (Barcelona Reward Music Questionnaire)
* Questionnaire SHAPS (Snaith-Hamilton Pleasure Scale)
* Questionnaire LARS (Lille's Apathy Rating Scale)
* Questionnaire PHQ-9 (Patient Health Questionnaire 9 items)

Healthy control

Subjects aged over 60, with no known neurodegenerative disease, living at home with a relative in the Hérault département.

Group Type ACTIVE_COMPARATOR

neuropsychologist interview

Intervention Type BEHAVIORAL

It will take place either at the hospital or at the participant's home.

This interview will consist of :

* socio-demographic data collection
* neuropsychological tests:

* MMSE test (Mini Mental State Examination) cognitive function
* RL-RI-16 test (16-item free recall/indexed recall test)
* BECS test (Semantic knowledge assessment battery )
* WCST test (Wisconsin Card Sorting Test )
* Musical Cognition Test
* Help from the participant's relative to answer certain questions, in particular the MuseEQ-24 questionnaire

questionnaire

Intervention Type BEHAVIORAL

The participant answers questionnaires:

* Questionnaire MusEQ-24 self reported (Music Engagement Questionnaire)
* Questionnaire BMRQ (Barcelona Reward Music Questionnaire)
* Questionnaire SHAPS (Snaith-Hamilton Pleasure Scale)
* Questionnaire LARS (Lille's Apathy Rating Scale)
* Questionnaire PHQ-9 (Patient Health Questionnaire 9 items)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

neuropsychologist interview

It will take place either at the hospital or at the participant's home.

This interview will consist of :

* socio-demographic data collection
* neuropsychological tests:

* MMSE test (Mini Mental State Examination) cognitive function
* RL-RI-16 test (16-item free recall/indexed recall test)
* BECS test (Semantic knowledge assessment battery )
* WCST test (Wisconsin Card Sorting Test )
* Musical Cognition Test
* Help from the participant's relative to answer certain questions, in particular the MuseEQ-24 questionnaire

Intervention Type BEHAVIORAL

questionnaire

The participant answers questionnaires:

* Questionnaire MusEQ-24 self reported (Music Engagement Questionnaire)
* Questionnaire BMRQ (Barcelona Reward Music Questionnaire)
* Questionnaire SHAPS (Snaith-Hamilton Pleasure Scale)
* Questionnaire LARS (Lille's Apathy Rating Scale)
* Questionnaire PHQ-9 (Patient Health Questionnaire 9 items)

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 60 years and older
* French-speaking and volunteering for the study
* Living at home with a relative


* Biological diagnosis of probable Alzheimer's disease according to NINCDS-ADRDA criteria (McKhann et al., 1984)
* MMSE greater than or equal to 20


* Diagnosis of Idiopathic Parkinson's disease
* MMSE greater than or equal to 20

Exclusion Criteria

* No known neurological pathologies (epilepsy and other non-degenerative CNS diseases) or psychiatric disorders (chronic psychosis and psychotic episodes)
* Autistic disorders
* History of stroke or head trauma
* Unstable medical condition (cancer)
* Subject unable to read and/or write
* Hearing impairment without hearing aids
* Refusal of consent after information
* Persons unable to give consent, research carried out in emergency situations, etc.)
* Non-affiliation with a social security scheme
* Person deprived of liberty (by judicial or administrative decision, or forced hospitalization)
* Person under legal protection (guardianship, curatorship, legal protection)
* Person participating in another research project with an exclusion period still in progress
Minimum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Laboratoire EPSYLON

UNKNOWN

Sponsor Role collaborator

University Hospital, Montpellier

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

KARIM BENNYS, MD

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Montpellier

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Montpellier Seniors' Association

Montpellier, Hérault, France

Site Status NOT_YET_RECRUITING

CHU de Montpellier - CEPMo

Montpellier, Hérault, France

Site Status RECRUITING

CHU de Montpellier - CMRR

Montpellier, Hérault, France

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mikaël Genguelou, PhD

Role: CONTACT

06.04.45.37.94. ext. +33

KARIM BENNYS, MD

Role: CONTACT

04.67.33.72.32 ext. + 33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mikaël Guenguelou, PhD

Role: primary

06.04.45.37.94. ext. +33

Mahmoud CHARIF, MD

Role: primary

0467337413 ext. +33

Karim BENNYS, MD

Role: primary

04.67.33.60.29 ext. +33

References

Explore related publications, articles, or registry entries linked to this study.

Bian X, Wang Y, Zhao X, Zhang Z, Ding C. Does music therapy affect the global cognitive function of patients with dementia? A meta-analysis. NeuroRehabilitation. 2021;48(4):553-562. doi: 10.3233/NRE-210018.

Reference Type BACKGROUND
PMID: 33967069 (View on PubMed)

Zhang Y, Cai J, An L, Hui F, Ren T, Ma H, Zhao Q. Does music therapy enhance behavioral and cognitive function in elderly dementia patients? A systematic review and meta-analysis. Ageing Res Rev. 2017 May;35:1-11. doi: 10.1016/j.arr.2016.12.003. Epub 2016 Dec 23.

Reference Type BACKGROUND
PMID: 28025173 (View on PubMed)

van der Steen JT, van Soest-Poortvliet MC, van der Wouden JC, Bruinsma MS, Scholten RJ, Vink AC. Music-based therapeutic interventions for people with dementia. Cochrane Database Syst Rev. 2017 May 2;5(5):CD003477. doi: 10.1002/14651858.CD003477.pub3.

Reference Type BACKGROUND
PMID: 28462986 (View on PubMed)

Platel H, Eustache ML, Coppalle R, Viard A, Eustache F, Groussard M, Desgranges B. Boosting Autobiographical Memory and the Sense of Identity of Alzheimer Patients Through Repeated Reminiscence Workshops? Front Psychol. 2021 Feb 15;12:636028. doi: 10.3389/fpsyg.2021.636028. eCollection 2021.

Reference Type BACKGROUND
PMID: 33679562 (View on PubMed)

Morris IB, Vasudevan E, Schedel M, Weymouth D, Loomis J, Pinkhasov T, Muratori LM. Music to One's Ears: Familiarity and Music Engagement in People With Parkinson's Disease. Front Neurosci. 2019 Jun 25;13:661. doi: 10.3389/fnins.2019.00661. eCollection 2019.

Reference Type BACKGROUND
PMID: 31293379 (View on PubMed)

Machado Sotomayor MJ, Arufe-Giraldez V, Ruiz-Rico G, Navarro-Paton R. Music Therapy and Parkinson's Disease: A Systematic Review from 2015-2020. Int J Environ Res Public Health. 2021 Nov 4;18(21):11618. doi: 10.3390/ijerph182111618.

Reference Type BACKGROUND
PMID: 34770129 (View on PubMed)

Loas G, Duru C, Godefroy O, Krystkowiak P. Hedonic deficits in Parkinson's disease: is consummatory anhedonia specific? Front Neurol. 2014 Mar 10;5:24. doi: 10.3389/fneur.2014.00024. eCollection 2014.

Reference Type BACKGROUND
PMID: 24653714 (View on PubMed)

Groussard M, Chan TG, Coppalle R, Platel H. Preservation of Musical Memory Throughout the Progression of Alzheimer's Disease? Toward a Reconciliation of Theoretical, Clinical, and Neuroimaging Evidence. J Alzheimers Dis. 2019;68(3):857-883. doi: 10.3233/JAD-180474.

Reference Type BACKGROUND
PMID: 30883343 (View on PubMed)

Belfi AM, Moreno GL, Gugliano M, Neill C. Musical reward across the lifespan. Aging Ment Health. 2022 May;26(5):932-939. doi: 10.1080/13607863.2021.1871881. Epub 2021 Jan 14.

Reference Type BACKGROUND
PMID: 33442987 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RECHMPL23_0427

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Tailored Music Therapy for Dementia
NCT03011723 COMPLETED NA
Music for the Mind Study
NCT06866327 RECRUITING NA